ophthalmology times europe Brand Information

Article

Ophthalmology Times Europe

Ophthalmology Times Europeis a comprehensive publication covering the latest developments within the ophthalmic industry. With a broad focus on cataract, corneal and refractive surgery, glaucoma and vitreoretinal conditions, Ophthalmology Times Europe reports on all major news, events, surgical and clinical developments and industry trends in Europe, providing an accurate and timely resource for time-pressured ophthalmologists throughout the European community..

Don’t miss out. Subscribe today and get your career moving in the right direction!

» Subscribe to print

Oteurope.com

Oteurope.com delivers exclusive web content, audio clips, and the ability to research and contact over 50 healthcare travel staffing companies with ease.Add us to your bookmarks/favorites, or make us your homepage:

Add us to your bookmarks/favorites, or make us your homepage:


Social Media

 

 

Other Ophthalmology Times Europe features of interest

OTE E-news and Digest
Deliver’s a mix of insight, opinion, market analysis, and practice management ideas.

» Subscribe to OTE E-news and Digest

» View the most recent Digest Edition

Modern Medicine online is created especially for today’s time-starved nurses and physicians, and includes resources and tools to help improve patient care and practice management.

• ICD-9 Coding & Reimbursement Tools
• CME Center
• Coding Counselor
• Clinical Literature
• Formulary Counselor

Modern Medicine is the most comprehensive medical resource available on the web today. Designed to meet the evolving needs of today’s physicians, Modern Medicine includes information from trusted healthcare journals, powerful resource tools, decision support and advisory functions.

Modern Medicine. Healthy patients. Healthy practice.
Register for free access today.


Visit our Industry Matter page that offers comprehensive information for professionals » Go
Healthcare resources focusing on:
• Clinical • Legal • Personal Finance/Investing
• Practice Management • Employment • Reference
• Patient-Friendly Publications • Personal Training

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.